Publication | Open Access

Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group

Hematological MalignancyOncologyPediatric HematologyAppropriate Dose ReductionAcute Myeloid LeukemiaHematologyPediatricsNewborn MedicineMedicineInduction TherapyMyeloid Neoplasia